Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Reviews on Recent Clinical Trials|May 14, 2008
Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivityEnric Carcereny, Joan Maurel
Current Cancer Drug Targets|October 11, 2015
Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical PracticeJoan Maurel, Antonio Postigo
Current Opinion in Chemical Biology|October 8, 2023
Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancerHelena Oliveres, Marta Cascante, Joan Maurel
International Journal of Molecular Sciences|June 2, 2021
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer PatientsHelena Oliveres, David Pesántez, Joan Maurel
Expert Opinion on Investigational Drugs|December 1, 2019
MET inhibitors in cancer: pitfalls and challengesHelena Oliveres, Estela Pineda, Joan Maurel
Expert Review of Anticancer Therapy|June 9, 2006
Chemotherapy for elderly patients with advanced colorectal carcinomaRosa Gallego, Nuria Sanchez, Joan Maurel
World Journal of Gastroenterology|November 9, 2007
Is there a genetic signature for liver metastasis in colorectal cancer?Cristina Nadal, Joan Maurel, Pere Gascon
Nutricion Hospitalaria|February 22, 2011
Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutritionJoan Trabal, Pere Leyes, Maria Forga, et al.
EMBO Molecular Medicine|November 10, 2025
circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancerSilei Sui, Yuan Li, Joan Maurel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
Hepatocellular and biliary tract carcinomas: SEOM clinical guidelinesJaime Feliu, Javier Sastre, Joan Maurel, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Reviews on Recent Clinical Trials|May 14, 2008
Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivityEnric Carcereny, Joan Maurel
Current Cancer Drug Targets|October 11, 2015
Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical PracticeJoan Maurel, Antonio Postigo
Current Opinion in Chemical Biology|October 8, 2023
Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancerHelena Oliveres, Marta Cascante, Joan Maurel
International Journal of Molecular Sciences|June 2, 2021
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer PatientsHelena Oliveres, David Pesántez, Joan Maurel
Expert Opinion on Investigational Drugs|December 1, 2019
MET inhibitors in cancer: pitfalls and challengesHelena Oliveres, Estela Pineda, Joan Maurel
Expert Review of Anticancer Therapy|June 9, 2006
Chemotherapy for elderly patients with advanced colorectal carcinomaRosa Gallego, Nuria Sanchez, Joan Maurel
World Journal of Gastroenterology|November 9, 2007
Is there a genetic signature for liver metastasis in colorectal cancer?Cristina Nadal, Joan Maurel, Pere Gascon
Nutricion Hospitalaria|February 22, 2011
Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutritionJoan Trabal, Pere Leyes, Maria Forga, et al.
EMBO Molecular Medicine|November 10, 2025
circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancerSilei Sui, Yuan Li, Joan Maurel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
Hepatocellular and biliary tract carcinomas: SEOM clinical guidelinesJaime Feliu, Javier Sastre, Joan Maurel, et al.
Pageof 12